http://www.ovidrx.com
Ovid Therapeutics Inc. Company Intro
This is Ovid—where we are boldly transforming the lives of people affected by rare neurological diseases including Angelman syndrome, Fragile X syndrome and rare epilepsies.
Industry
Healthcare
Ovid Therapeutics Inc. Headquaters
1460 Broadway
New York,10036
United States
Ovid Therapeutics Inc. Share price
17 May 2023 13:41 GMT
$3.4400
-0.06 (-1.71 %)
Ovid Therapeutics Inc. Market cap
$249.617 M
WMC RANKING
2024
Ovid Therapeutics Inc. # 44
BiotechnologyLatest Ovid Therapeutics Inc. News
08 Feb 2024
Epilepsy Market Size in the 7MM was ~USD 8600 Million in 2022, estimates DelveInsight |
The Epilepsy Market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period (2023-2034). Furthermore,
08 Feb 2024
Epilepsy Market to Observe Stunning Growth by 2032, Predicts DelveInsight | Key Players in the Market - Xenon ...
The dynamics of the epilepsy market are anticipated to change in the coming years owing to the improvement in the diagnosis methodologies, rising awareness.
08 Feb 2024
Epilepsy Market to Observe Stunning Growth by 2032, Predicts DelveInsight | Key Players in the Market - Xenon ...
The dynamics of the epilepsy market are anticipated to change in the coming years owing to the improvement in the diagnosis methodologies, rising awareness.
WMC Market Score
WMC Market to Revenue Score
Ovid Therapeutics Inc. Market Financials
Revenue, Expenses, Profit
| Company | Currency | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| Ovid Therapeutics Inc. | USD | $221,000 | $105,579 | $115,002 | $2,496M | 44 |
| Regeneron Pharmaceuticals, Inc. | USD | $9,197,600 | $3,997,800 | $4,003,800 | $804,390B | 1 |
| Vertex Pharmaceuticals Incorporated | USD | $6,414,881 | $2,617,257 | $2,762,032 | $878,880B | 2 |
| Alexion Pharmaceuticals, Inc. | USD | $6,261,601 | $2,747,200 | $681,800 | $ 0.00 | 3 |
| ALK-Abello A/S | USD | $3,556,000 | $1,893,000 | $66,000 | $189,400B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total Ovid Therapeutics Inc. Social Followers vs Top 4 Industry Competitors
Ovid Therapeutics Inc. Post vs Top 4 Industry Competitors
Ovid Therapeutics Inc. Digital Footprint By Size vs Top 4 Industry Competitors
Ovid Therapeutics Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors
Ovid Therapeutics Inc. WMC Market Score Calculations
| Details | Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score |
| Ovid Therapeutics Inc. | 2.40 | 1.95 | 0.05 | 0 | 0 | 0 | 0.71 |
| Regeneron Pharmaceuticals, Inc. | 100 | 25.50 | 16.15 | 70 | 0 | 0 | 39.85 |
| Vertex Pharmaceuticals Incorporated | 69.75 | 35.68 | 8.95 | 100 | 0 | 0 | 51.56 |
| Alexion Pharmaceuticals, Inc. | 68.08 | 100 | 100 | 80 | 0 | 0 | 100 |
| ALK-Abello A/S | 38.66 | 0 | 0 | 0 | 0 | 0 | 0 |
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge
